Assessment of vascular maturation in non-small cell lung cancer using a novel basement membrane component, LH39: correlation with p53 and angiogenic factor expression - PubMed (original) (raw)
. 1999 Nov 1;59(21):5602-7.
Affiliations
- PMID: 10554041
Assessment of vascular maturation in non-small cell lung cancer using a novel basement membrane component, LH39: correlation with p53 and angiogenic factor expression
S Kakolyris et al. Cancer Res. 1999.
Abstract
Angiogenesis, the formation of new vessels, has been demonstrated to be a potent and independent indicator of prognosis in non-small cell lung cancer patients. The extent of differentiation of the tumor vessels may affect access of peripheral white cells and egress or invasion of tumor cells. This has not been assessed in relation to tumor microvessel density or other variables and may be a marker of vascular remodeling. LH39 is a monoclonal antibody recognizing an epitope located at the lamina lucida of mature small veins and capillaries but not in newly formed vessels. We examined the ratio of mature:immature vessels in 81 non-small cell lung carcinomas and correlated the vascular maturation index (VMI) to different clinicopathological variables including angiogenesis. Mature vessels were defined by staining with antibodies to both LH39 and to CD31, using double immunohistochemistry, whereas immature vessels stained only for CD31. VMI was defined as the percentage fraction of mature vessels (LH39 positive)/total number of vessels (CD31 positive). The median VMI in lung carcinomas was 46% (range, 15-90%). There was a significant inverse correlation between high VMI and low thymidine phosphorylase expression (P = 0.0001), high VMI and nuclear p53 negativity (P = 0.01), high VMI and low angiogenesis (P = 0.0001), as well as between high VMI and absence of nodal involvement (P = 0.01). Low angiogenesis and high VMI were associated with a significantly better outcome (P = 0.0001 and P = 0.02, respectively). These findings show that there is a wide variation in the differentiation of tumor vasculature in lung carcinomas, and VMI gives new information on the degree of active tumor vascular remodeling independently from microvessel quantitation.
Similar articles
- Assessment of vascular maturation in lung and breast carcinomas using a novel basement membrane component, LH39.
Kakolyris S, Giatromanolaki A, Koukourakis M, Kaklamanis L, Kouroussis CH, Bozionelou V, Georgoulias V, Gatter KC, Harris AL. Kakolyris S, et al. Anticancer Res. 2001 Nov-Dec;21(6B):4311-6. Anticancer Res. 2001. PMID: 11908685 - Relationship of vascular maturation in breast cancer blood vessels to vascular density and metastasis, assessed by expression of a novel basement membrane component, LH39.
Kakolyris S, Fox SB, Koukourakis M, Giatromanolaki A, Brown N, Leek RD, Taylor M, Leigh IM, Gatter KC, Harris AL. Kakolyris S, et al. Br J Cancer. 2000 Feb;82(4):844-51. doi: 10.1054/bjoc.1999.1010. Br J Cancer. 2000. PMID: 10732757 Free PMC article. - Comparative evaluation of angiogenesis assessment with anti-factor-VIII and anti-CD31 immunostaining in non-small cell lung cancer.
Giatromanolaki A, Koukourakis MI, Theodossiou D, Barbatis K, O'Byrne K, Harris AL, Gatter KC. Giatromanolaki A, et al. Clin Cancer Res. 1997 Dec;3(12 Pt 1):2485-92. Clin Cancer Res. 1997. PMID: 9815651 - Prognostic role of angiogenesis in non-small cell lung cancer.
Giatromanolaki A. Giatromanolaki A. Anticancer Res. 2001 Nov-Dec;21(6B):4373-82. Anticancer Res. 2001. PMID: 11908693 Review. - [Angiogenesis and neoangiogenesis--the role in lung cancer and other tumors].
Swidzińska E, Naumnik W, Chyczewska E. Swidzińska E, et al. Pneumonol Alergol Pol. 2006;74(4):414-20. Pneumonol Alergol Pol. 2006. PMID: 17427152 Review. Polish. No abstract available.
Cited by
- Prognostic impact of VEGF, CD31, CD34, and CD105 expression and tumour vessel invasion after radical surgery for IB-IIA non-small cell lung cancer.
Mineo TC, Ambrogi V, Baldi A, Rabitti C, Bollero P, Vincenzi B, Tonini G. Mineo TC, et al. J Clin Pathol. 2004 Jun;57(6):591-7. doi: 10.1136/jcp.2003.013508. J Clin Pathol. 2004. PMID: 15166262 Free PMC article. - Interactive Verification Analysis of Multiple Sequencing Data for Identifying Potential Biomarker of Lung Adenocarcinoma.
Fei H, Chen S, Xu C. Fei H, et al. Biomed Res Int. 2020 Oct 1;2020:8931419. doi: 10.1155/2020/8931419. eCollection 2020. Biomed Res Int. 2020. PMID: 33062704 Free PMC article. - The role of microvessel density on the survival of patients with lung cancer: a systematic review of the literature with meta-analysis.
Meert AP, Paesmans M, Martin B, Delmotte P, Berghmans T, Verdebout JM, Lafitte JJ, Mascaux C, Sculier JP. Meert AP, et al. Br J Cancer. 2002 Sep 23;87(7):694-701. doi: 10.1038/sj.bjc.6600551. Br J Cancer. 2002. PMID: 12232748 Free PMC article. - Breast tumour angiogenesis.
Fox SB, Generali DG, Harris AL. Fox SB, et al. Breast Cancer Res. 2007;9(6):216. doi: 10.1186/bcr1796. Breast Cancer Res. 2007. PMID: 18190723 Free PMC article. Review. - Tumor vascular maturation and improved drug delivery induced by methylselenocysteine leads to therapeutic synergy with anticancer drugs.
Bhattacharya A, Seshadri M, Oven SD, Tóth K, Vaughan MM, Rustum YM. Bhattacharya A, et al. Clin Cancer Res. 2008 Jun 15;14(12):3926-32. doi: 10.1158/1078-0432.CCR-08-0212. Clin Cancer Res. 2008. PMID: 18559614 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical
Research Materials
Miscellaneous